OA
DXCM icon

Operose Advisors’s DexCom DXCM Stock Holding History

Operose Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-175
Closed -$11.7K – 495
2024
Q3 		$11.7K Hold
175
– – ﹤0.01% 475
2024
Q2 		$19.8K Hold
175
– – 0.01% 355
2024
Q1 		$24.3K Hold
175
– – 0.01% 356
2023
Q4 		$21.7K Hold
175
– – 0.01% 352
2023
Q3 		$16.3K Buy
+175
New +$19.7K 0.01% 502

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Operose Advisors's DXCM Position: Q4 2024 in Review

Operose Advisors sold out of DexCom (DXCM) in Q4 2024, closing a stake of 175 shares — an estimated $11.7K sold.

Operose Advisors first reported a position in DXCM in Q3 2023 and held it in 5 quarters. The position peaked at $24.3K in Q1 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Operose Advisors reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Operose Advisors sold 175 DexCom shares in Q4 2024, an estimated $11.7K.
  • Operose Advisors first reported a position in DexCom in Q3 2023 and held it in 5 quarters.
  • Operose Advisors's DexCom position peaked at $24.3K in Q1 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Operose Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.